How are symptomatic enteroenteric fistulas treated in inflammatory bowel disease (IBD)?

Updated: Apr 10, 2020
  • Author: William A Rowe, MD; Chief Editor: BS Anand, MD  more...
  • Print

Symptomatic enteroenteric fistulas are generally resected, although recurrence is common. Postoperative medical therapy often prevents recurrence, although data are lacking regarding efficacy. A meta-analysis of nine randomized trials suggested that 5-ASA preparations provide a very modest benefit for maintenance. [87] The preferred program of prevention varies between immunomodulators and biologic therapy.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!